Barclays’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,700
Closed -$23K 6871
2019
Q3
$23K Buy
+1,700
New +$23.7K ﹤0.01% 6184
2018
Q4
Sell
-1,000
Closed -$23K 7384
2018
Q3
$23K Buy
1,000
+900
+900% +$18.4K ﹤0.01% 6430
2018
Q2
$2K Sell
100
-2,600
-96% -$43.5K ﹤0.01% 6851
2018
Q1
$45K Sell
2,700
-3,300
-55% -$55.2K ﹤0.01% 5977
2017
Q4
$91K Sell
6,000
-1,000
-14% -$14.8K ﹤0.01% 5316
2017
Q3
$125K Buy
7,000
+6,900
+6,900% +$115K ﹤0.01% 4771
2017
Q2
$2K Hold
100
﹤0.01% 6449
2017
Q1
$1K Sell
100
-8,200
-99% -$117K ﹤0.01% 6641
2016
Q4
$132K Sell
8,300
-8,900
-52% -$143K ﹤0.01% 4554
2016
Q3
$287K Buy
17,200
+13,800
+406% +$186K ﹤0.01% 3669
2016
Q2
$38K Buy
3,400
+2,000
+143% +$19.4K ﹤0.01% 4987
2016
Q1
$11K Sell
1,400
-9,600
-87% -$78.8K ﹤0.01% 5452
2015
Q4
$99K Buy
11,000
+9,300
+547% +$92.8K ﹤0.01% 4410
2015
Q3
$19K Sell
1,700
-2,500
-60% -$30.6K ﹤0.01% 5486
2015
Q2
$50K Sell
4,200
-134,400
-97% -$1.45M ﹤0.01% 5141
2015
Q1
$1.25M Sell
138,600
-14,000
-9% -$158K ﹤0.01% 2766
2014
Q4
$2.14M Buy
152,600
+140,200
+1,131% +$1.66M ﹤0.01% 2473
2014
Q3
$124K Sell
12,400
-19,300
-61% -$253K ﹤0.01% 5159
2014
Q2
$507K Sell
31,700
-31,700
-50% -$422K ﹤0.01% 3955
2014
Q1
$1.01M Buy
63,400
+14,800
+30% +$210K ﹤0.01% 3221
2013
Q4
$583K Buy
48,600
+11,100
+30% +$111K ﹤0.01% 3942
2013
Q3
$375K Sell
37,500
-324,200
-90% -$3.46M ﹤0.01% 4427
2013
Q2
$2.92M Buy
+361,700
New +$2.44M 0.01% 2121

Other funds holding VNDA